Results 211 to 220 of about 32,179 (263)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1930
The red marrow of the bones makes erythrocytes, granular leukocytes and platelets. In agranulocytosis, the factory that makes the granulocytes has shut down. The life of this cell in the normal conditions of health is three days or more,1and from three to five days by other evidences.
STEWART R. ROBERTS, ROY R. KRACKE
openaire +2 more sources
The red marrow of the bones makes erythrocytes, granular leukocytes and platelets. In agranulocytosis, the factory that makes the granulocytes has shut down. The life of this cell in the normal conditions of health is three days or more,1and from three to five days by other evidences.
STEWART R. ROBERTS, ROY R. KRACKE
openaire +2 more sources
Clinics in Haematology, 1980
Drug-induced agranulocytosis is relatively rare. It is a heterogeneous disorder in pathogenetic terms, not surprisingly in view of its idosyncratic nature. Indeed, one drug might cause agranulocytosis by different mechanisms in different patients. Recent investigations suggest that there are at least three mechanisms by which it can be produced, namely
G A, Young, P C, Vincent
openaire +2 more sources
Drug-induced agranulocytosis is relatively rare. It is a heterogeneous disorder in pathogenetic terms, not surprisingly in view of its idosyncratic nature. Indeed, one drug might cause agranulocytosis by different mechanisms in different patients. Recent investigations suggest that there are at least three mechanisms by which it can be produced, namely
G A, Young, P C, Vincent
openaire +2 more sources
Journal of the American Medical Association, 1946
To the Editor:— Our recent experience with penicillin in the treatment of thiouracil induced agranulocytosis has created in our minds a point of view at variance with the report of the Council on Pharmacy and Chemistry of February 9. We are referring to the recommendation that a daily dosage of 500,000 units is the desirable method of treatment in ...
M G, VORHAUS, H H, ROTHENDLER
openaire +2 more sources
To the Editor:— Our recent experience with penicillin in the treatment of thiouracil induced agranulocytosis has created in our minds a point of view at variance with the report of the Council on Pharmacy and Chemistry of February 9. We are referring to the recommendation that a daily dosage of 500,000 units is the desirable method of treatment in ...
M G, VORHAUS, H H, ROTHENDLER
openaire +2 more sources
Propafenone Associated Agranulocytosis
Pacing and Clinical Electrophysiology, 1992Propafenone hydrochloride was approved for marketing by the United States (U.S.) Food and Drug Administration (FDA) in November 1989. During U.S. clinical trials of propafenone, one case of agranulocytosis was seen. Seven additional cases have been reported outside the U.S. One German report of profound but reversible granulocytopenia appeared in 1982.
L J, Miwa, H M, Jolson
openaire +2 more sources
Medical Toxicology, 1988
Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic type of drug reaction more than 50 years ago, its pathogenesis is still not fully understood. Drug-related antibodies are responsible for the neutropenia in the so-called 'immune' or 'aminopyrine' type of agranulocytosis ...
openaire +2 more sources
Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic type of drug reaction more than 50 years ago, its pathogenesis is still not fully understood. Drug-related antibodies are responsible for the neutropenia in the so-called 'immune' or 'aminopyrine' type of agranulocytosis ...
openaire +2 more sources